PolyPid Ltd.
PolyPid is a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing, and commercializing novel, locally administered therapies to improve surgical outcomes. Their proprietary PLEX platform enables localized, controlled, and prolonged drug release solutions, aiming to enhance patient outcomes in conditions such as infection, pain, inflammation, and cancer.
Industries
Nr. of Employees
medium (51-250)
PolyPid Ltd.
18 Hasivim Street, P.O Box 7126, Petach Tikva, Israel 4917002
Patents
Compositions and methods for the treatment and prophylaxis of surgical site infections
US-11975101-B2
View DetailsCompositions and methods for the treatment and prophylaxis of surgical site infections
US-11471414-B2
View Details
Compositions and methods for the treatment and prophylaxis of surgical site infections
US-11975101-B2
View DetailsCompositions and methods for the treatment and prophylaxis of surgical site infections
US-11471414-B2
View DetailsProducts
Local extended‑release doxycycline implant for surgical sites
An implantable matrix formulated to deliver doxycycline locally at surgical sites over approximately four weeks to reduce the risk of surgical site infections while limiting systemic exposure.
Antibiotic‑eluting β‑TCP granules for bone infection applications
Granular β‑tricalcium phosphate material formulated to elute antibiotics locally for treatment or prevention of bone‑related infections.
Local extended‑release doxycycline implant for surgical sites
An implantable matrix formulated to deliver doxycycline locally at surgical sites over approximately four weeks to reduce the risk of surgical site infections while limiting systemic exposure.
Antibiotic‑eluting β‑TCP granules for bone infection applications
Granular β‑tricalcium phosphate material formulated to elute antibiotics locally for treatment or prevention of bone‑related infections.
Services
Licensing or partnership arrangements to enable use of a localized sustained‑release drug delivery system by third parties for optimized local therapeutic delivery.
Manufacturing services including GMP production and manufacturing process validation for platform-enabled products and clinical/commercial supply.
Licensing or partnership arrangements to enable use of a localized sustained‑release drug delivery system by third parties for optimized local therapeutic delivery.
Manufacturing services including GMP production and manufacturing process validation for platform-enabled products and clinical/commercial supply.
Expertise Areas
- Localized drug delivery
- Sustained‑release formulation development
- Surgical therapeutics (surgical site infection prevention)
- Clinical trial management for surgical indications
Key Technologies
- Polymer‑lipid layered encapsulation matrices
- Controlled‑release drug reservoirs
- Antibiotic‑eluting beta‑tricalcium phosphate granules
- Local implantable extended‑release systems